VAN KAMPEN TRUST FOR INSURED MUNICIPALS
NSAR-B, EX-27, 2000-12-29
Previous: VAN KAMPEN TRUST FOR INSURED MUNICIPALS, NSAR-B, EX-99, 2000-12-29
Next: AMYLIN PHARMACEUTICALS INC, DEFS14A, 2000-12-29



<TABLE> <S> <C>

<ARTICLE>                                            6
<SERIES>
   <NUMBER>                                         11
   <NAME>                       TRUST FOR INSURED MUNI
<MULTIPLIER>                                         1

<S>                                                <C>
<PERIOD-TYPE>                                   12-MOS
<FISCAL-YEAR-END>                          OCT-31-2000
<PERIOD-START>                             NOV-01-1999
<PERIOD-END>                               OCT-31-2000
<INVESTMENTS-AT-COST>                      240,002,820
<INVESTMENTS-AT-VALUE>                     249,872,307
<RECEIVABLES>                                5,923,418
<ASSETS-OTHER>                                   5,944
<OTHER-ITEMS-ASSETS>                            61,917
<TOTAL-ASSETS>                             255,863,586
<PAYABLE-FOR-SECURITIES>                    10,489,328
<SENIOR-LONG-TERM-DEBT>                              0
<OTHER-ITEMS-LIABILITIES>                      643,277
<TOTAL-LIABILITIES>                         11,132,605
<SENIOR-EQUITY>                             90,000,000
<PAID-IN-CAPITAL-COMMON>                   143,817,671
<SHARES-COMMON-STOCK>                        9,741,284
<SHARES-COMMON-PRIOR>                        9,741,284
<ACCUMULATED-NII-CURRENT>                      224,554
<OVERDISTRIBUTION-NII>                               0
<ACCUMULATED-NET-GAINS>                        819,269
<OVERDISTRIBUTION-GAINS>                             0
<ACCUM-APPREC-OR-DEPREC>                     9,869,487
<NET-ASSETS>                               244,730,981
<DIVIDEND-INCOME>                                    0
<INTEREST-INCOME>                           14,687,101
<OTHER-INCOME>                                       0
<EXPENSES-NET>                              (2,426,251)
<NET-INVESTMENT-INCOME>                     12,260,850
<REALIZED-GAINS-CURRENT>                     2,252,498
<APPREC-INCREASE-CURRENT>                    3,705,514
<NET-CHANGE-FROM-OPS>                       18,218,862
<EQUALIZATION>                                       0
<DISTRIBUTIONS-OF-INCOME>                  (13,041,561)
<DISTRIBUTIONS-OF-GAINS>                             0
<DISTRIBUTIONS-OTHER>                                0
<NUMBER-OF-SHARES-SOLD>                              0
<NUMBER-OF-SHARES-REDEEMED>                          0
<SHARES-REINVESTED>                                  0
<NET-CHANGE-IN-ASSETS>                       5,177,301
<ACCUMULATED-NII-PRIOR>                      1,005,069
<ACCUMULATED-GAINS-PRIOR>                   (1,433,229)
<OVERDISTRIB-NII-PRIOR>                              0
<OVERDIST-NET-GAINS-PRIOR>                           0
<GROSS-ADVISORY-FEES>                        1,443,578
<INTEREST-EXPENSE>                                   0
<GROSS-EXPENSE>                              2,426,251
<AVERAGE-NET-ASSETS>                       150,314,421
<PER-SHARE-NAV-BEGIN>                            15.35
<PER-SHARE-NII>                                   1.26
<PER-SHARE-GAIN-APPREC>                           0.61
<PER-SHARE-DIVIDEND>                             (1.34)
<PER-SHARE-DISTRIBUTIONS>                         0.00
<RETURNS-OF-CAPITAL>                              0.00
<PER-SHARE-NAV-END>                              15.88
<EXPENSE-RATIO>                                   1.61


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission